Calyxt Inc (NASDAQ:CLXT) has been given a consensus rating of “Buy” by the seven analysts that are currently covering the firm, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $24.71.
A number of brokerages recently commented on CLXT. Zacks Investment Research raised shares of Calyxt from a “hold” rating to a “buy” rating and set a $15.00 price objective on the stock in a research report on Thursday, October 11th. Goldman Sachs Group began coverage on shares of Calyxt in a research report on Friday, September 7th. They set a “neutral” rating and a $18.00 price objective on the stock. ValuEngine raised shares of Calyxt from a “hold” rating to a “buy” rating in a research report on Friday, July 20th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $27.00 price objective on shares of Calyxt in a research report on Friday, June 22nd.
Calyxt stock opened at $12.76 on Tuesday. The company has a market capitalization of $438.94 million, a PE ratio of -11.39 and a beta of 3.61. The company has a current ratio of 21.27, a quick ratio of 21.27 and a debt-to-equity ratio of 0.16. Calyxt has a fifty-two week low of $12.52 and a fifty-two week high of $27.23.
In related news, insider Daniel F. Voytas sold 4,666 shares of the business’s stock in a transaction that occurred on Monday, August 20th. The shares were sold at an average price of $17.31, for a total transaction of $80,768.46. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Manoj Sahoo sold 2,521 shares of the business’s stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $14.84, for a total transaction of $37,411.64. The disclosure for this sale can be found here. Insiders have sold 25,219 shares of company stock worth $402,335 over the last ninety days. 2.80% of the stock is currently owned by insiders.
A number of hedge funds have recently bought and sold shares of CLXT. Wells Fargo & Company MN grew its position in Calyxt by 23.6% in the first quarter. Wells Fargo & Company MN now owns 38,048 shares of the company’s stock worth $500,000 after acquiring an additional 7,260 shares in the last quarter. Perkins Capital Management Inc. bought a new stake in Calyxt in the second quarter worth approximately $833,000. Granite Investment Partners LLC bought a new stake in Calyxt in the second quarter worth approximately $216,000. BlackRock Inc. grew its position in Calyxt by 21.8% in the second quarter. BlackRock Inc. now owns 733,554 shares of the company’s stock worth $13,696,000 after acquiring an additional 131,265 shares in the last quarter. Finally, PNC Financial Services Group Inc. bought a new stake in Calyxt in the second quarter worth approximately $186,000. 28.07% of the stock is owned by institutional investors.
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans.
See Also: 52-Week High/Low
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.